Huazhong University of Science and Technology

HUTCHMED Announces that the Sovleplenib Phase III ESLIM-01 Study Met Its Primary Endpoint in Primary Immune Thrombocytopenia in China

Retrieved on: 
Monday, August 21, 2023
Huazhong University of Science and Technology, Bleeding, Hematology, SC, Medicine, New Drug Application, NDA, ITP, Huachung University, Committee, Breakthrough therapy, Tongji Medical College, HKEX, Peking Union Medical College, The Lancet, Patient, Risk, Union Hospital, National Medical Products Administration, Principal, Safety, NMPA, Wuhan Union Hospital, Disease, Bone marrow, Pharmaceutical industry, Nursing, FC, MD

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Aug. 20, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that the pivotal Phase III trial ESLIM-01 evaluating the investigational use of sovleplenib met its primary endpoint of durable response rate and all secondary endpoints in adult patients with primary immune thrombocytopenia (“ITP”) in China. HUTCHMED plans to submit the New Drug Application (“NDA”) around the end of 2023.

Key Points: 
  • The National Medical Products Administration of China (“NMPA”) granted Breakthrough Therapy designation (“BTD”) to sovleplenib for the indication studied in ESLIM-01 in January 2022.
  • As such, the sovleplenib NDA may be considered for priority review for its use in ITP.
  • ESLIM-01 is a randomized, double-blinded, placebo-controlled Phase III trial in China of sovleplenib in 188 adult patients with primary ITP who have received at least one prior line of standard therapy.
  • Sovleplenib is a novel, selective, oral inhibitor targeting spleen tyrosine kinase (“Syk”) for the treatment of hematological malignancies and immune diseases.

IASO Bio and Innovent Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel（BCMA CAR-T Cell Therapy）for Multiple Myeloma at the 2023 ASCO Annual Meeting

Retrieved on: 
Monday, June 5, 2023
Tongji Hospital station, DNA, Fragment crystallizable region, Pi, Biotechnology, SCR, CRS, Hook effect, DOR, B-cell maturation antigen, American Society of Clinical Oncology, Bone marrow, Huachung University, Cmax, Doctor of Philosophy, PFS, Trial of the century, MTTR, ASCO, MRD, CAR, Tongji Medical College, CR, Congress, Multiple myeloma, MD, Patient, Cytokine release syndrome, SAN, EMM, Annual general meeting, Immunotherapy, EHA, MM, RRMM, Huazhong University of Science and Technology, Proteasome inhibitor, Society, ADA, ORR, BCMA, Safety, Center for Innovative Phage Applications and Therapeutics, Disease, Vaccine, Pharmaceutical industry

The updated data showed long-term follow-up efficacy and safety of the phase 1b/2 study (FUMANBA-1) conducted in 14 centers in China.

Key Points: 
  • The updated data showed long-term follow-up efficacy and safety of the phase 1b/2 study (FUMANBA-1) conducted in 14 centers in China.
  • Among the 103 patients, 68.9% (71/103) had high-risk cytogenetic abnormalities per mSMART 3.0, 12.6%（13/103）had extramedullary multiple myeloma (EMM), and 11.7%（12/103）had received prior CAR-T therapy.
  • Equecabtagene Autoleucel demonstrated a favorable and manageable safety profile: Among the 103 patients, 93.2% (96/103) experienced cytokine release syndrome (CRS).
  • These results are encouraging and entails an opportunity to advance Equecabtagene Autoleucel to earlier lines of treatment to benefit more MM patients."

HYZON MOTORS ANNOUNCES SUE SUN-LASOVAGE AS CHIEF HUMAN RESOURCES OFFICER

Retrieved on: 
Monday, May 1, 2023
Learning, VIA Motors, Human resources, Tesco international operations, University, SRG Global, Culture, Huazhong University of Science and Technology, CHRO, Hyzon Motors, UCA Division I-A College National Championship, HR, Growth, OEM, Transport, Management

ROCHESTER, N.Y., May 1, 2023 /PRNewswire/ -- Hyzon Motors Inc. (NASDAQ: HYZN), a global supplier of zero-emission heavy-duty fuel cell electric vehicles, today announced Sue Sun-LaSovage will join Hyzon as Chief Human Resources Officer (CHRO), effective May 2, 2023. In this new role for Hyzon, Sun-LaSovage will lead the company's global human resources team overseeing recruitment, management, learning, and development in support of the company's overall growth.

Key Points: 
  • ROCHESTER, N.Y., May 1, 2023 /PRNewswire/ -- Hyzon Motors Inc. (NASDAQ: HYZN), a global supplier of zero-emission heavy-duty fuel cell electric vehicles, today announced Sue Sun-LaSovage will join Hyzon as Chief Human Resources Officer (CHRO), effective May 2, 2023.
  • In this new role for Hyzon, Sun-LaSovage will lead the company's global human resources team overseeing recruitment, management, learning, and development in support of the company's overall growth.
  • Sun-LaSovage is a seasoned human resources leader with more than two decades of experience in organizational development, employee engagement, and HR strategy.
  • This announcement follows the appointments Hyzon has made in recent months including CEO Parker Meeks, interim Chief Financial Officer Jiajia Wu, Chief Operating Officer Dr. Bappa Banerjee, President of International Operations John Edgley, and President of North America Pat Griffin.

Phoenix Motorcars Promotes Dr. Frank Lee and Adds Dr. Joseph Xiang to Senior Management Team

Retrieved on: 
Monday, April 24, 2023
Automotive Manufacturing, EV, Electric Vehicles, Automotive, Manufacturing, Trucking, Transport, General Automotive, Alternative Vehicles, Fuels, Logistics, Supply Chain Management, Alternative Energy, Energy, Karma, MSEE, Ohio State University, BS, University, Smart electric drive, MI, Visteon, Engineering, ICE, PEV, PHEV, Ford, Huachung University, EREV, BYD Auto, BSEE, Karma Automotive, Huazhong University of Science and Technology, Geely, Corporation, CFO, Knowledge, Phoenix Motorcars, Management, Electricity, Mechanics

“We are proud to be able to attract such talented, seasoned industry veterans,” said Dr. Lance Zhou, CEO of Phoenix Motorcars.

Key Points: 
  • “We are proud to be able to attract such talented, seasoned industry veterans,” said Dr. Lance Zhou, CEO of Phoenix Motorcars.
  • “The promotion of Frank and the addition of Joseph to our senior management team further positions Phoenix for success as we continue to execute on our global growth strategy.”
    Chris Wang, CFO of Phoenix Motorcars, commented, “The promotion of Frank and addition of Joseph lends additional knowledge and expertise to our operational and technical capabilities.
  • I am proud of the team we have built and our successes to date.
  • Dr. Joseph Xiang brings 35 years of engineering experience, with more than 25 years in the automotive arena.

Intellectual Property Litigation Partner Hui Shen Joins Dorsey

Retrieved on: 
Tuesday, January 24, 2023
Other Professional Services, Professional Services, Legal, Patent, Huachung University, Partner, Radio, University of Virginia, Dorsey & Whitney, University, United States International Trade Commission, Huazhong University of Science and Technology, IP, Multimedia, Steptoe & Johnson, American University, 3D printing

International law firm Dorsey & Whitney LLP is pleased to announce that Dr. Hui Shen has joined Dorsey as a Partner in the Intellectual Property Litigation group in Washington, DC.

Key Points: 
  • International law firm Dorsey & Whitney LLP is pleased to announce that Dr. Hui Shen has joined Dorsey as a Partner in the Intellectual Property Litigation group in Washington, DC.
  • View the full release here: https://www.businesswire.com/news/home/20230124005946/en/
    Intellectual Property Litigation Partner Hui Shen Joins Dorsey (Photo: Business Wire)
    Hui represents technology companies in complex intellectual property disputes involving trade secret misappropriation, patent infringement, and copyright infringement.
  • “Hui’s extensive network in China makes him a great fit for our international platform,” said Bill Stoeri, Managing Partner of Dorsey.
  • “Dorsey has an ideal platform for my practice,” said Dr. Hui Shen.

CAHE Hosts 2022 Annual International Forum on Higher Education in Collaboration with HUST

Retrieved on: 
Friday, December 2, 2022
Education, Other Education, University, Sustainable development, UNESCO, Huazhong University of Science and Technology, HUST, Huachung University, Renewable energy, Management, Education

The 2022 Annual International Forum on Higher Education has taken place in Wuhan.

Key Points: 
  • The 2022 Annual International Forum on Higher Education has taken place in Wuhan.
  • This forum, hosted by the China Association of Higher Education (CAHE) in collaboration with Huazhong University of Science and Technology (HUST), under the theme "Community with a Shared Future for Mankind and Sustainable Development of Higher Education", the forum involved three parallel sessions: University Presidents Forum, Scholars Forum, and Doctoral Candidates Forum, as well as other side events such as UNESCO Sub-Forum and U.S.-China University Dialogue, aiming at an international academic exchange platform for higher education.
  • He noted that the advancement of sustainable development of China's higher education should center around the important mission of cultivating talents, promote high-level opening-up in all aspects, at all levels, on a wide scope and in a proactive manner, deeply engage in global education governance, and contribute Chinese wisdom to the sustainable development of global higher education.
  • Du Yubo, President of CAHE and former Vice Minister of Education, believes that to advance the sustainable development of global higher education, it is necessary to press ahead with strategic endeavors of higher education digitalization, and develop a new pattern of international exchanges and cooperation.

Phoenix Motorcars Further Strengthens Its Senior Management Team by Adding Dr. Frank Lee and Dr. Bo Yang

Retrieved on: 
Friday, October 28, 2022
Automotive Manufacturing, EV, Electric Vehicles, Automotive, Manufacturing, Public Transport, Trucking, Transport, Alternative Vehicles, Fuels, Logistics, Supply Chain Management, Alternative Energy, Energy, Karma, MS, Ford Motor Company, Company, SEC, University, EREV, General Motors, VP, Private Securities Litigation Reform Act, Nasdaq, Forward-looking statement, Zhejiang University, Goal, BS, Veteran, CEO, BYD Auto, Senior, PHEV, PEV, Materials science, ICE, Industry, Risk, EV, Light, CA, Process engineering, Karma Automotive, Huachung University, Review, EVS, California Air Resources Board, Knowledge, Ohio State University, Materials Science and Engineering, Moses Austin, Technology, Huazhong University of Science and Technology, Geely, Management, Risk management, Mechanics, Engineering

In commenting on the appointments, Dr. Lance Zhou, CEO of Phoenix Motor Inc., said, We are excited to add such experienced veterans to the team.

Key Points: 
  • In commenting on the appointments, Dr. Lance Zhou, CEO of Phoenix Motor Inc., said, We are excited to add such experienced veterans to the team.
  • Bo will utilize his vast experience in fuel cells and zero-emission, heavy duty trucks and buses to develop and monetize our fuel cell assets.
  • Dr. Lee most recently served as Vice President of Vehicle Integration at Karma Automotive, an Irvine, CA based EV manufacturer.
  • Dr. Bo Yang brings 21 years of experience, primarily in fuel cell power systems and zero-emission heavy duty trucks and buses.

UTStarcom Announces Management Changes

Retrieved on: 
Friday, September 2, 2022
People, Telecommunication, Internal audit, UTStarcom, Human resources, Compensation, ONS, Doctorate, GLOBE, Compliance, Huazhong University of Science and Technology, Company, Financial system, Levi, Electrical engineering, Xi'an Jiaotong University, Carol Yinghua Lu, GTS, Administration, Mechanical, Compensation & Benefits Review, Senior Consultant, HRP, McGill University, Investment Technology Group, Treasury, Shanghai University, Guosen Securities, IPTV, Technology, Desautels Faculty of Management, Systems engineering, NASDAQ, Nasdaq Market Makers Antitrust Litigation, CDMA, HR, Optics, Corporate finance, Automation, HRA, Huachung University, Recruitment, CTO, McGill University Faculty of Engineering, Zhejiang University, Graduate diploma, UTSI, Marketing, Mechanical engineering, Management, Engineering, Huawei

He has held various management positions in UTs Finance department, including Treasury, Tax, Technical Accounting, Internal Audit and Compliance.

Key Points: 
  • He has held various management positions in UTs Finance department, including Treasury, Tax, Technical Accounting, Internal Audit and Compliance.
  • Before joining UTStarcom, Dan worked as an auditor at Levi, Yetnikoff Chartered Accountants.
  • Since joining UTStarcom in 2005, she took various HR and Administration management roles, including the functions of HRBP, Compensation & Benefit, Recruitment and People Development, etc.
  • UTStarcom is committed to helping network operators offer their customers the most innovative, reliable and cost-effective communication services.

VNET Announces Changes to Board and Committees Composition

Retrieved on: 
Tuesday, August 9, 2022
Board of directors, United Kingdom, Rule, Board, The Company, VNET, Company, Niu Technologies, Hong Kong Stock Exchange, University of Warwick, NASDAQ, Huachung University, Technology, Journalism, Huazhong University of Science and Technology, Property management, Limited, Nasdaq

In addition, the Company announced the following changes to the committees of the Board:

Key Points: 
  • In addition, the Company announced the following changes to the committees of the Board:
    The Board appointed Mr. Sheng Chen as a member of the compensation committee of the Board and a member of the nominating and corporate governance committee of the Board.
  • The Board also approved that Mr. Kenneth Chung-Hou Tai will no longer serve as a member of the audit committee of the Board and Mr. Erhfei Liu will no longer serve as a member of the compensation committee of the Board.
  • These changes to the committees of the Board became effective August 9, 2022.
  • The following table sets forth the composition of the committees of the Board immediately following the appointment of the new director and the changes to the committee members.

Tongji Hospital Begins Installation of Mevion Proton Therapy System

Retrieved on: 
Thursday, August 4, 2022
Research, Hospitals, Health Technology, Other Health, Health, General Health, Other Science, Science, Oncology, Proton, Neoplasm, Varian Medical Systems, Proton therapy, Education, NMPA, PET/CT, PBS, Technology, Central, Tongji Hospital station, National Medical Products Administration, Patient, Multimedia, Huachung University, Tongji Medical College, Scan (company), Hospital, LinkedIn, Research, Science, Cancer, Faculty, Tongji, Risk, Huazhong University of Science and Technology, Partnership, Growth, Medical imaging, Central China

Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the accelerator for the MEVION S250i Proton Therapy System was delivered on July 28, 2022, to Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology in Wuhan, China.

Key Points: 
  • Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that the accelerator for the MEVION S250i Proton Therapy System was delivered on July 28, 2022, to Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology in Wuhan, China.
  • This milestone commences the system installation at Tongji Hospitals proton therapy center, the first of its kind in Central China.
  • View the full release here: https://www.businesswire.com/news/home/20220804005161/en/
    Mevion begins system installation at Tongji Hospital in Wuhan, China (Photo: Business Wire)
    The system at Tongji Hospital features Mevions industry leading HYPERSCAN Pencil Beam Scanning (PBS) technology and Adaptive Aperture pMLC.
  • Mevions flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the worlds smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems.